Product Manager @ CellMax Life

People in the News at CellMax Life, Jackson Lab, BC Platforms, GeneDx

Thursday, 06 April 2023 / Published in In the News

Apr 06, 2023 – Molecular diagnostics company CellMax Life has appointed Stan Lapidus and Ron Andrews to its

CellMax Life Announces Expansion of Company Board With Leading Industry Experts

Thursday, 06 April 2023 / Published in Press Releases

Feb 21, 2023 – Renowned industry experts support the company as it prepares for premarket approval studies

CellMax Life Announces Expansion of GI Medical Advisory Board

Tuesday, 21 February 2023 / Published in Press Releases

Feb 21, 2023 – Renowned industry experts support the company as it prepares for premarket approval studies

Dr. Friedland on a Multimodal Screening Blood Test to Detect CRC

Friday, 17 February 2023 / Published in In the News

Feb 10, 2023 – Shai Friedland, MD, discusses a multimodal screening blood test for advanced adenomas in colorectal cancer.

CellMax Life announced positive results from a multisite U.S. study that showed that its FirstSight blood test is highly accurate in detecting colorectal cancer and advanced adenomas. 

Friday, 27 January 2023 / Published in In the News

Jan 26, 2023 – CellMax Life announced positive results from a multisite U.S. study that showed that its FirstSight blood test is highly accurate in detecting colorectal cancer and advanced adenomas. 

Colorectal Cancer Detection Data from CellMax Life Bodes Well for Planned FDA Bid

Thursday, 19 January 2023 / Published in In the News

NEW YORK; Jan 19, 2023 – Cancer screening firm CellMax Life shared new data this week from a multi-site prospective study of its blood-based colorectal cancer detection assay, FirstSight.

CellMax Life Announces Positive Results From Prospective Multisite Study of Novel Blood Test to Detect Colorectal Cancer and Pre-Cancer

Thursday, 19 January 2023 / Published in Press Releases

SUNNYVALE, CA; January 18, 2023 – CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood test, today announced positive results from a multisite U.S. study that showed that its FirstSight blood test is highly accurate in detecting colorectal cancer, as well as advanced adenomas.

CellMax Life’s Cancer Blood Test Designated FDA Breakthrough Device

Monday, 30 August 2021 / Published in In the News

FDANews; August 30, 2021 – Molecular diagnostics company CellMax Life’s FirstSight pre-cancer and cancer detection blood test has received the FDA’s Breakthrough Device designation.

In Brief This Week: Mount Sinai Health System, Sophia Genetics, CellMax Life, and More

Friday, 27 August 2021 / Published in In the News

GenomeWeb; August 27, 2021 – CellMax Life said this week that its FirstSight colorectal precancer and cancer detection blood test has received Breakthrough Device Designation from the US Food and Drug Administration.

CellMax Life gets FDA breakthrough device status for pre-cancer and cancer detection blood test

Thursday, 26 August 2021 / Published in In the News

Aug. 26, 2021 – The FirstSight blood test is a liquid biopsy, which will help measure colorectal neoplasia associated epithelial cells and DNA markers in human blood